Section Arrow
Quote
ITCI.NASDAQ
- Intra-Cellular Therapies
Quotes are at least 15-min delayed:2024/09/21 05:18 EDT
Last
 77.59
+0.62 (+0.81%)
Day High 
78.15 
Prev. Close
76.97 
1-M High
78.14 
Volume 
845.89K 
Bid
70.01
Ask
83.35
Day Low
76.8 
Open
77 
1-M Low
71.75 
Market Cap 
8.13B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 74.89 
20-SMA 74.12 
50-SMA 75.78 
52-W High 84.89 
52-W Low 45.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.86/0.66
Enterprise Value
8.15B
Balance Sheet
Book Value Per Share
10.83
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
462.18M
Operating Revenue Per Share
0.35
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
VTRSViatris11.39-0.51-4.29%227.2PE
TLRYTilray Brands1.71-0.07-3.93%-- 
TEVATeva Pharmaceutical Industries Limited17.51-0.25-1.41%-- 
ELANElanco Animal Health14.07-1-6.64%-- 
IRWDIronwood Pharmaceuticals4.305-0.205-4.55%56.38PE
Quotes are at least 15-min delayed：2024/09/21 05:18 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that addressneeds in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.